Global POC Infectious Diseases Market 2015-2019 is the latest addition to Sandlerresearch.org industry research reports collection. The analysts forecast global POC infectious disease market to grow at a CAGR of 7.50% over the period 2014-2019. Read this 72 Pages report on Global POC Infectious Diseases Market 2015-2019; the report provides 31 List of Exhibits. POC diagnosis for infectious diseases refers to diagnostic tests performed near the site of patient care. The testing site is usually a patient’s bedside, physician’s clinic, ICU, operating room, emergency room, or wherever medical care may be necessary. A healthcare professional or a nurse attending the patient will obtain the specimen, perform analysis, and record the result. The main purpose of POC testing is to decrease the time between diagnosis and treatment. This test is either antibody-based or microbial particle-based detection method, which includes ELISA, agglutination, optical immunoassays, or lateral flow immunochromatography. Advances in POC technology has facilitated in data storage and data sharing and communication with public health agencies. Performing this test for screening infectious diseases extends its applications to the community practice setting. For instance, processing accurate data on the prevalence of influenza in community could help curtail inappropriate use of antibacterial agents and improve the allocation of vaccines to areas of highest need. Covered in this report The report covers present scenario and the growth prospects of the global POC infectious disease market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of testing kits and devices used for the major POC infectious diseases in the market. Based on diseases, the market can be divided into 10: flu, tuberculosis, malaria, RSV, adenovirus, infectious mononucleosis, fecal occult blood, HIV, strep. B, others (HCV, HBV, giardia, syphilis, and pneumonia). The report, Global POC Infectious Disease Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA; it also covers the global POC infectious disease market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market. Purchase a Report Copy at http://www.sandlerresearch.org/purchase?rname=36025 . Alternatively get Discount on the Report at http://www.sandlerresearch.org/discount?rname=36025 . Key regions
Americas APAC EMEA
Key vendors
Alere Meridian Bioscience Orasure Technologies Trinity Biotech
Other prominent vendors
Abbott Beckman Coulter/ Danaher Becton Dickinson Biomerieux Bio-Rad Cepheid Diamedix Diasorin Eiken Chemical Enzo Biochem Fujirebio/ Innogenetics Grifols/ Novartis Diagnostics Humor Diagnostica Hologic/ Gen-Probe Nanogen/ Elitech Ortho-Clinical Diagnostics/ Johnson & Johnson Qiagen Roche Diagnostics SeraCare Siemens Healthcare Thermo Fisher Scientific
Inquire before Buying at http://www.sandlerresearch.org/inquire-before-buying?rname=36025 . Key Market Driver: Increase in prevalence of infectious diseases Key Market Challenge: Lack of awareness about POC devices Key Market Trend: Shift from physician-centered to patient-centered model Key questions answered in this report
1. 2. 3. 4. 5. 6. 7.
What will the market size be in 2019 and what will the growth rate be? What are the key market trends? What is driving this market? What are the challenges to market growth? Who are the key vendors in this market space? What are the market opportunities and threats faced by the key vendors? What are the strengths and weaknesses of the key vendors?
List of Exhibits: Exhibit 1: Market research methodology Exhibit 2: POC testing market segmentation Exhibit 3: Categorization of infectious diseases Exhibit 4: HAIs in US Exhibit 5: Estimated treatment cost and mortality associated with HAIs Exhibit 6: Segmentation of HAI Exhibit 7: Global POC infectious diseases market 2014-2019 ($ million) Exhibit 8: Segmentation of market by disease types 2014 Exhibit 9: Regional malaria deaths Exhibit 10: Regional malaria cases Exhibit 11: WHO regional tuberculosis statistics Exhibit 12: Demographic statistics for HIV Exhibit 13: POC infectious diseases market by geography 2014 Exhibit 14: POC infectious diseases market by geography 2019 Exhibit 15: Segmentation of global POC infectious diseases market by geography 2014-2019 Exhibit 16: POC infectious diseases market in Americas 2014-2019 ($ million) Exhibit 17: POC infectious diseases market in EMEA 2014-2019 ($ million) Exhibit 18: POC infectious diseases market in APAC 2014-2019 ($ million)
Exhibit 19: Global POC Infectious Diseases Market: business segmentation by revenue 2013 Exhibit 20: Global POC Infectious Diseases Market: business segmentation by revenue 2012 and 2013 ($ billion) Exhibit 21: Global POC Infectious Diseases Market: geographical segmentation by revenue 2013 Exhibit 22: Meridian: business segmentation by revenue 2014 Exhibit 23: Meridian: business segmentation by revenue 2013 and 2014 ($ million) Exhibit 24: Meridian: geographical segmentation by revenue 2014 Exhibit 25: OraSure: product segmentation Exhibit 26: OraSure: business segmentation by revenue 2014 Exhibit 27: OraSure: business segmentation by revenue 2013 and 2014 ($ million) Exhibit 28: OraSure: geographical segmentation by revenue 2014 Exhibit 29: Trinity Biotech: business segmentation by revenue 2013 Exhibit 30: Trinity Biotech: business segmentation by revenue 2012 and 2013 ($ million) Exhibit 31: Trinity Biotech: geographical segmentation by revenue 2013 Browse Other Reports on Diagnostics . Contact sales@sandlerresearch.org / Call +1 888 391 5441 for further information on “Global POC Infectious Diseases Market 2015-2019� report OR for any other market research and intelligence needs you may have for your business. NOTE: This Report Is NOT Free Of Charge.